SCHEMBL1889538

SCHEMBL1889538

CCOC(=O)n1nc(NC(=O)c2ccc(N3CCN(C)CC3)cc2F)c2c1CCN(C(=O)OC(C)(C)C)C2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIT P10721 1/20 0.39
FLT3 P36888 1/20 0.39
USP30 Q70CQ3 2/20 0.39
MAP3K5 Q99683 5/20 0.38
BTK Q06187 1/20 0.37
WDR5 P61964 1/20 0.37
TMEM97 Q5BJF2 2/20 0.36
SIGMAR1 Q99720 2/20 0.36
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PLK4 O00444 1/20 0.35
DAPK3 O43293 1/20 0.35
NTRK1 P04629 1/20 0.35
PRKCG P05129 1/20 0.35
ROS1 P08922 1/20 0.35
FER P16591 1/20 0.35
LTK P29376 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1890065 0.89 SIRT6 (0.40) TMEM97SIGMAR1MAPTSMN1; SMN2
SCHEMBL4281362 0.86 ALK (0.39) WDR5MEN1MAPTTSHRKMT2A
SCHEMBL1895334 0.82 MAPT (0.39) MEN1MAPTTSHRKMT2ASMN1; SMN2
SCHEMBL2678300 0.82 KIT (0.43) KITFLT3BTKWDR5PLK4
Hydrochloric Acid SCHEMBL2678295 0.82 KIT (0.42) KITFLT3BTKWDR5PLK4
SCHEMBL1891508 0.81 MTOR (0.40) MEN1MAPTKMT2A
SCHEMBL2921535 0.81 SMN1; SMN2 (0.48) KITFLT3BTKMEN1MAPT
SCHEMBL15338600 0.79 ALK (0.42) MAPTPLK4DAPK3NTRK1PRKCG
SCHEMBL4287277 0.77 WDR5 (0.37) KITFLT3USP30MAP3K5BTK
SCHEMBL1890828 0.77 AKR1B10 (0.40) MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173659-B2 Substituted pyrazolo[4,3-C]pyridine derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-05-08 US disclosed
US-20110230470-A1 SUBSTITUTED PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-09-22 US disclosed
US-7947686-B2 Substituted pyrazolo[4,3-c]pyridine derivatives active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2011-05-24 US disclosed
US-20090023745-A1 Substituted Pyrazolo[4,3-c]Pyridine Derivatives Active as Kinase Inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2009-01-22 US disclosed
EP-1968976-A1 SUBSTITUTED PYRAZOLO [4,3-C] PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.r.l. (IT) 2008-09-17 EP disclosed
WO-2007068619-A1 SUBSTITUTED PYRAZOLO [4,3-C] PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2007-06-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230470-A1 SUBSTITUTED PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES ACTIVE AS KINASE INHIBITORS MAP3K3, MAP3K1, MAP3K19 KIT 481/4885FLT3 244/4885USP30 3118/4885
US-20090023745-A1 Substituted Pyrazolo[4,3-c]Pyridine Derivatives Active as Kinase Inhibitors MAP3K3, MAP3K1, MAP3K19 KIT 481/4885FLT3 244/4885USP30 3118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.